• 

  Merck & Co at a Crossroads with the Next Warfarin Heart Drug

  By Claire Al-Aufi on April 4, 2012

  Vorapaxar, Merck & Co’s latest heart medication is not good enough for patients and may be very bad for Merck. The company is at a...

Copyright © 2013 Hive Health Media. A Whipp Media Property.